Back to R2 link
Top Industry News
- MHRA -Guidance on Software and Artificial Intelligence (AI) as a Medical Device
- FDA Finalizes Guidance on Drug Quality Consensus Standards Recognition Program
- MHRA Labelling and Packaging of Medicinal Products for Human Use Following Agreement of the Windsor Framework
- PMDA Updated "Methods for Submitting Materials for Document Compliance Inspections of Pharmaceuticals and Regenerative Medicine Products and GCP/GPSP on-site inspections through the gateway system
- EMA Seeks Feedback on Plans to Update Pair of Radiopharmaceutical Guidance Documents
- FDA Assessing User Fees Under the Biosimilar User Fee Amendments of 2022
- PMDA Updated Information on Humanitarian Clinical Trials (Drugs, Devices/Refurbishment)
- Proposed Commission Delegated Regulation Amending Commission Delegated Regulation (EU) 2021/1342 Concerning the Information Required from Third countries, control Authorities, and Control Bodies for the Purpose of Recognition Supervision Under Article 33(2) and (3) of Council Regulation (EC) No 834/2007, and the Corresponding Measures for Exercising Such Supervision
- Argentina Updates Argentine Food Code for Gluten-Free Foods
- TGA Seeks Feedback on Proposed Medical Device Application Audit Framework
- Pakistan’s DRAP Starts Consultation on Harmonizing Healthcare Marketing Data Submissions
- A Preliminary Opinion On Water-Soluble Zinc Salts Utilized In Oral Hygiene Products has been Issued by SCCS (Scientific Committee on Consumer Safety)
- Health Canada's Ongoing Public Consultations on MRLs